Avexima JSC is a modern, fast-growing pharmaceutical manufacturing company belonging to a new generation of pharmaceutical manufacturers. We conduct our activities in accordance with innovative pharmaceutical market development trends and international quality standards.
Avexima pharmaceutical company was established in 2011. In the short period of time we managed to create and launch highly demanded medicines available for all social categories.
The company manufactures its own medicines at the manufacturing sites of two large Russian pharmaceutical enterprises having a long-time history: Avexima Siberia LLC and Irbit Chemical and Pharmaceutical Plant JSC. Our investment in renovation of manufacturing, new manufacturing sites construction, provision with modern pharmaceutical equipment and technologies in accordance with the requirements of international GMP standards allows the plants to manufacture high-quality medicines. Those are one of few Russian enterprises preserving the technology of complex synthesis of Russian-manufactured pharmaceutical substances that meet the requirements of the Import Substitution Program and ensure pharmaceutical independence of the country.
Today Avexima JSC is a full cycle pharmaceutical company conducting its activities in three main areas: development, manufacturing and promotion of drug products.
The list of finished dosages forms includes the products for treatment of gynecological, urological, cardiovascular, neurological, gastrointestinal, musculoskeletal diseases, as well as antimicrobial medicines, vitamins, anti-cold medicines and analgesics. In the coming years Avexima is willing to enlarge its product portfolio with modern, innovative and high-quality medicines.